Cargando…

Establishment and validation of a prognostic nomogram based on a novel five‐DNA methylation signature for survival in endometrial cancer patients

BACKGROUND: This study aimed to explore the prognostic role of DNA methylation pattern in endometrial cancer (EC) patients. METHODS: Differentially methylated genes (DMGs) of EC patients with distinct survival from The Cancer Genome Atlas (TCGA) database were analyzed to identify methylated genes as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xingchen, Yin, Fufen, Fan, Yuan, Cheng, Yuan, Dong, Yangyang, Zhou, Jingyi, Wang, Zhiqi, Li, Xiaoping, Wang, Jianliu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877372/ https://www.ncbi.nlm.nih.gov/pubmed/33350104 http://dx.doi.org/10.1002/cam4.3576

Ejemplares similares

Development and Validation of Nomograms Predicting the Overall and the Cancer-Specific Survival in Endometrial Cancer Patients
por: Li, Xingchen, et al.
Publicado: (2020)

A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation
por: Yang, Xiao, et al.
Publicado: (2021)

Mechanical Stimulus-Related Risk Signature Plays a Key Role in the Prognostic Nomogram For Endometrial Cancer
por: Xu, Xin, et al.
Publicado: (2021)

Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer
por: Cheng, Yuan, et al.
Publicado: (2021)

Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer
por: Yang, Xiao, et al.
Publicado: (2022)

An Externally Validated Nomogram for Predicting Lymph Node Metastasis of Presumed Stage I and II Endometrial Cancer
por: Dong, Yangyang, et al.
Publicado: (2019)

Predicting prognosis of endometrioid endometrial adenocarcinoma on the basis of gene expression and clinical features using Random Forest
por: Yin, Fufen, et al.
Publicado: (2019)

Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation
por: Cheng, Yuan, et al.
Publicado: (2020)

Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients
por: Fan, Yuan, et al.
Publicado: (2021)

Prior Tubal Ligation Might Influence Metastatic Spread of Nonendometrioid Endometrial Carcinoma
por: Li, Mingxia, et al.
Publicado: (2016)

Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients
por: Li, Xingchen, et al.
Publicado: (2023)

Effects of Metabolic Syndrome and Its Components on the Prognosis of Endometrial Cancer
por: Yang, Xiao, et al.
Publicado: (2021)

Development and Validation of a Nomogram Based on Metabolic Risk Score for Assessing Lymphovascular Space Invasion in Patients with Endometrial Cancer
por: Wang, Jingyuan, et al.
Publicado: (2022)

An elevated preoperative serum calcium level is a significant predictor for positive peritoneal cytology in endometrial carcinoma
por: Li, Xingchen, et al.
Publicado: (2019)

Calcium and TRPV4 promote metastasis by regulating cytoskeleton through the RhoA/ROCK1 pathway in endometrial cancer
por: Li, Xingchen, et al.
Publicado: (2020)

Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center
por: Dai, Yibo, et al.
Publicado: (2019)

Glutamine and amino acid metabolism as a prognostic signature and therapeutic target in endometrial cancer
por: Zhai, Lirong, et al.
Publicado: (2023)

A detailed analysis of lymph node recurrence in endometrial carcinoma
por: Li, He, et al.
Publicado: (2022)

Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma
por: Wu, Mengwei, et al.
Publicado: (2019)

Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
por: Fan, Yuan, et al.
Publicado: (2021)

Identification of a six‐gene signature with prognostic value for patients with endometrial carcinoma
por: Wang, Yizi, et al.
Publicado: (2018)

Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
por: Ding, Yingqiao, et al.
Publicado: (2022)

Establishment of a nine‐gene prognostic model for predicting overall survival of patients with endometrial carcinoma
por: Ying, Jianchao, et al.
Publicado: (2018)

Insulin Resistance and Metabolic Syndrome Increase the Risk of Relapse For Fertility Preserving Treatment in Atypical Endometrial Hyperplasia and Early Endometrial Cancer Patients
por: Li, Xingchen, et al.
Publicado: (2021)

Comparison of Survival Benefits of Combined Chemotherapy and Radiotherapy Versus Chemotherapy Alone for Uterine Serous Carcinoma: A Meta-analysis
por: Lin, Yanying, et al.
Publicado: (2017)

The Ratio of Neutrophil to Lymphocyte is a Predictor in Endometrial Cancer
por: Dong, Yangyang, et al.
Publicado: (2019)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer
por: Liu, Wenli, et al.
Publicado: (2021)

Development of a nomogram for prognostic prediction of lower‐grade glioma based on alternative splicing signatures
por: Wang, Yaning, et al.
Publicado: (2020)

Reconstruction of Immune Microenvironment and Signaling Pathways in Endometrioid Endometrial Adenocarcinoma During Formation of Lymphovascular Space Involvement and Lymph Node Metastasis
por: Cheng, Yuan, et al.
Publicado: (2020)

Role of steroid receptor-associated and regulated protein in tumor progression and progesterone receptor signaling in endometrial cancer
por: Liu, Jie, et al.
Publicado: (2023)

Identification of Interleukin-9 Producing Immune Cells in Endometrial Carcinoma and Establishment of a Prognostic Nomogram
por: Tong, Huan, et al.
Publicado: (2020)

Targeting Cancer Metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with Metformin for Endometrial Cancer Patients with Diabetes
por: Yang, Xiao, et al.
Publicado: (2022)

MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer
por: Fan, Xingchen, et al.
Publicado: (2021)

Gefitinib enhances sensitivity of endometrial cancer cells to progestin therapy via dual-specificity phosphatase 1
por: Yang, Yuan, et al.
Publicado: (2017)

Competing risk nomogram predicting cancer‐specific mortality for endometrial cancer patients treated with hysterectomy
por: Xie, Guilan, et al.
Publicado: (2021)

Prognostic nomogram based on immune scores for breast cancer patients
por: Wang, Ju, et al.
Publicado: (2019)

Development and validation of a nomogram to predict synchronous lung metastases in patients with ovarian cancer: a large cohort study
por: Yuan, Yufei, et al.
Publicado: (2020)

A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy
por: Liang, Jie‐ying, et al.
Publicado: (2021)

Heterogeneity of CD40 Expression in Different Types of High-Risk Endometrial Cancer Affects Discordant Prognostic Outcomes
por: Zhao, Na, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g5bklg92onshj420arl130gp2n